Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Ophthalmology, the Second People's Hospital of Yunnan Province (Fourth Affiliated Hospital of Kunming Medical University), Yunnan Eye Institute, Key Laboratory of Yunnan Province for the Prevention and Treatment of Ophthalmology (2017DG008), Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People's Hospital of Yunnan Province (2017HC010), Expert Workstation of Yao Ke (2017IC064), Kunming, China.
J Cell Mol Med. 2019 Mar;23(3):1678-1686. doi: 10.1111/jcmm.14158. Epub 2019 Jan 18.
Trabecular meshwork (TM) contains a subset of adult stem cells or progenitors that can be differentiated into corneal endothelial cells, adipocytes and chondrocytes, but not osteocytes or keratocytes. Accordingly, these progenitors can be utilized as a cell-based therapy to prevent blindness caused by glaucoma, corneal endothelial dysfunction and other diseases in general. In this review, we review in vitro expansion techniques for TM progenitors, discuss their phenotypic properties, and highlight their potential clinical applications in various ophthalmic diseases.
小梁网(TM)包含一组成人干细胞或祖细胞,这些细胞可分化为角膜内皮细胞、脂肪细胞和成软骨细胞,但不能分化为成骨细胞或角膜细胞。因此,这些祖细胞可以用作基于细胞的治疗方法,以预防青光眼、角膜内皮功能障碍和其他一般疾病引起的失明。在这篇综述中,我们回顾了 TM 祖细胞的体外扩增技术,讨论了它们的表型特性,并强调了它们在各种眼科疾病中的潜在临床应用。